NLRP3 and obesity disorder: Our study uncovers a role for RIPK3/caspase-8 signaling in regulating obesity-induced inflammation, independent of its capacity to activate NLRP3, aligning with recent reports in sepsis and arthritis models (Allam et al, 2014; Lawlor et al, 2015).